메뉴 건너뛰기




Volumn 145, Issue 3, 2010, Pages 422-425

Clinical predictors of stent thrombosis in the "real world" drug-eluting stent era

Author keywords

Drug eluting stent; Percutaneous coronary intervention; Predictors; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

EID: 78649933026     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.05.038     Document Type: Article
Times cited : (9)

References (15)
  • 1
    • 0037422604 scopus 로고    scopus 로고
    • TAXUS I: Six and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions
    • E. Grube, S. Silber, and K.E. Hauptmann TAXUS I: six and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions Circulation 107 2003 38 42
    • (2003) Circulation , vol.107 , pp. 38-42
    • Grube, E.1    Silber, S.2    Hauptmann, K.E.3
  • 2
    • 11144357913 scopus 로고    scopus 로고
    • One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial
    • G.W. Stone, S.G. Ellis, and D.A. Cox One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial Circulation 109 2004 1942 1947
    • (2004) Circulation , vol.109 , pp. 1942-1947
    • Stone, G.W.1    Ellis, S.G.2    Cox, D.A.3
  • 3
    • 33644967633 scopus 로고    scopus 로고
    • Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare metal stents: The TAXUS-V ISR randomized trial
    • G.W. Stone, S.G. Ellis, and C.D. O'Shaughnessy Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare metal stents: the TAXUS-V ISR randomized trial JAMA 295 2006 1253 1263
    • (2006) JAMA , vol.295 , pp. 1253-1263
    • Stone, G.W.1    Ellis, S.G.2    O'Shaughnessy, C.D.3
  • 4
    • 10744222911 scopus 로고    scopus 로고
    • Analysis of 1-year clinical outcomes in the SIRIUS trial: A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis
    • D.R. Holmes Jr, M.B. Leon, and J.W. Moses Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis Circulation 109 2004 634 640
    • (2004) Circulation , vol.109 , pp. 634-640
    • Holmes Jr., D.R.1    Leon, M.B.2    Moses, J.W.3
  • 5
    • 1542708491 scopus 로고    scopus 로고
    • The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de nove lesions in small native coronary arteries (C-SIRIUS)
    • E. Schampaert, E.A. Cohen, and M. Schluter The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de nove lesions in small native coronary arteries (C-SIRIUS) J Am Coll Cardiol 43 2004 1110 1115
    • (2004) J Am Coll Cardiol , vol.43 , pp. 1110-1115
    • Schampaert, E.1    Cohen, E.A.2    Schluter, M.3
  • 6
    • 0037030658 scopus 로고    scopus 로고
    • RAVEL, a randomized comparison of a sirolimus-eluting stent with a std. stent for coronary revascularization
    • M. Morice, P. Serruya, and J.E. Sousa RAVEL, a randomized comparison of a sirolimus-eluting stent with a std. stent for coronary revascularization N Eng J Med 346 2002 1773 1780
    • (2002) N Eng J Med , vol.346 , pp. 1773-1780
    • Morice, M.1    Serruya, P.2    Sousa, J.E.3
  • 7
    • 33947494324 scopus 로고    scopus 로고
    • TCT daily: ESTROFA: Late thrombosis not increased in des patients: Spanish registry of drug-eluting stents shows STEMI, LAD artery lesions, significant risk factors
    • J. Kahn TCT daily: ESTROFA: late thrombosis not increased in DES patients: Spanish registry of drug-eluting stents shows STEMI, LAD artery lesions, significant risk factors J Interv Cardiol 20 2007 32
    • (2007) J Interv Cardiol , vol.20 , pp. 32
    • Kahn, J.1
  • 8
    • 17844373254 scopus 로고    scopus 로고
    • Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
    • I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
    • (2005) JAMA , vol.293 , pp. 2126-2130
    • Iakovou, I.1    Schmidt, T.2    Bonizzoni, E.3
  • 9
    • 20044388113 scopus 로고    scopus 로고
    • Drug-eluting stent thrombosis: Result from pooled analysis including ten randomized trials
    • R. Moreno, C. Fernandez, and R. Hernandez Drug-eluting stent thrombosis: result from pooled analysis including ten randomized trials J Am Coll Cardiol 45 2005 954 959
    • (2005) J Am Coll Cardiol , vol.45 , pp. 954-959
    • Moreno, R.1    Fernandez, C.2    Hernandez, R.3
  • 10
    • 33846828736 scopus 로고    scopus 로고
    • Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians
    • C.L. Grines, R.O. Bonow, and D.E. Casey Jr. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians J Am Coll Cardiol 49 2007 734 739
    • (2007) J Am Coll Cardiol , vol.49 , pp. 734-739
    • Grines, C.L.1    Bonow, R.O.2    Casey, Jr.D.E.3
  • 11
    • 32844458145 scopus 로고    scopus 로고
    • Aspirin resistance
    • G.J. Hankey, and J.W. Eikelboom Aspirin resistance Lancet 367 2006 606 617
    • (2006) Lancet , vol.367 , pp. 606-617
    • Hankey, G.J.1    Eikelboom, J.W.2
  • 12
    • 17144370263 scopus 로고    scopus 로고
    • Resistance to clopidogrel: A review of evidence
    • T.A. Nguyen, and J.G. Diodati Resistance to clopidogrel: a review of evidence J Am Coll Cardiol 45 2005 1157 1164
    • (2005) J Am Coll Cardiol , vol.45 , pp. 1157-1164
    • Nguyen, T.A.1    Diodati, J.G.2
  • 13
    • 0038649988 scopus 로고    scopus 로고
    • Clopidogrel for coronary stenting: Response variability, drug resistance and the effect of pre-treatment platelet reactivity
    • P.A. Gurbel, K.P. Bliden, and B.L. Hiatt Clopidogrel for coronary stenting: response variability, drug resistance and the effect of pre-treatment platelet reactivity Circulation 107 2003 2908 2913
    • (2003) Circulation , vol.107 , pp. 2908-2913
    • Gurbel, P.A.1    Bliden, K.P.2    Hiatt, B.L.3
  • 14
    • 23844482612 scopus 로고    scopus 로고
    • Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: Meta-analysis of randomized trials
    • A. Kastrati, A. Dibra, and S. Eberle Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials JAMA 294 2005 819 825
    • (2005) JAMA , vol.294 , pp. 819-825
    • Kastrati, A.1    Dibra, A.2    Eberle, S.3
  • 15
    • 57549110416 scopus 로고    scopus 로고
    • Ethical authorship and publishing
    • A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150
    • (2009) Int J Cardiol , vol.131 , pp. 149-150
    • Coats, A.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.